Jarvinen L Z, Hogenesch H, Suckow M A, Bowersock T L
Veterinary Pathobiology, Purdue University, West Lafayette, Indiana 47907, USA.
Infect Immun. 1998 Aug;66(8):3788-95. doi: 10.1128/IAI.66.8.3788-3795.1998.
Pasteurella multocida is a bacterial pathogen that causes rhinitis (snuffles), pneumonia, otitis media, septicemia, metritis, and death in domestic rabbits. Currently, there are no effective vaccines to prevent infection by this organism. Subcutaneous (s.c.) immunization with either exotoxin or thiocyanate extracts of P. multocida induces partial protection in rabbits. Since disease begins at mucosal sites, induction of local immunity may be important in preventing systemic disease. Little is known concerning the efficacy of intranasal (i.n. ) administration of these antigens in inducing protective mucosal immunity to P. multocida in rabbits. The purpose of this study was twofold: (i) to investigate the effectiveness of vaccination with purified P. multocida toxin (PMT) and a potassium thiocyanate extract of P. multocida (CN) in combination and (ii) to evaluate the efficacy of administration of these antigens i.n. versus s.c. Forty-eight rabbits were randomly divided into eight different treatment groups. Rabbits received either one or both antigens by either s.c. or i.n. administration. Following vaccination, each group received an i.n. challenge of P. multocida. Rabbits vaccinated with both antigens i.n. or s.c. had a 100% survival rate, few or no bacteria in the liver and lungs, high serum immunoglobulin G (IgG) and IgM antibody titers, and significant numbers of IgG antibody-secreting cells (ASC) in the spleen and tracheobronchial lymph node. Rabbits vaccinated i.n. had significant nasal and bronchoalveolar lavage IgA antibody levels. Rabbits vaccinated with only one antigen, either PMT or CN, had lower antibody titers, moderate to severe liver and lung infections, and fewer ASC compared to rabbits receiving both antigens. Rabbits in the control groups had moderate to severe liver and lung infections. This study indicates that i.n. immunization with both PMT and CN induces an effective response against homologous P. multocida challenge.
多杀性巴氏杆菌是一种可导致家兔患鼻炎(鼻塞)、肺炎、中耳炎、败血症、子宫炎并死亡的细菌病原体。目前,尚无有效疫苗可预防该病原体感染。用多杀性巴氏杆菌的外毒素或硫氰酸盐提取物进行皮下免疫可使家兔获得部分保护。由于疾病始于黏膜部位,诱导局部免疫对于预防全身性疾病可能很重要。关于鼻内给予这些抗原诱导家兔对多杀性巴氏杆菌产生保护性黏膜免疫的效果,人们了解甚少。本研究的目的有两个:(i)研究联合使用纯化的多杀性巴氏杆菌毒素(PMT)和多杀性巴氏杆菌的硫氰酸钾提取物(CN)进行疫苗接种的有效性;(ii)评估这些抗原经鼻内给药与皮下给药的效果。48只家兔被随机分为8个不同的治疗组。家兔通过皮下或鼻内给药接受一种或两种抗原。接种疫苗后,每组家兔接受一次多杀性巴氏杆菌的鼻内攻毒。经鼻内或皮下接种两种抗原的家兔存活率为100%,肝脏和肺部细菌很少或没有,血清免疫球蛋白G(IgG)和IgM抗体滴度高,脾脏和气管支气管淋巴结中有大量IgG抗体分泌细胞(ASC)。经鼻内接种的家兔鼻和支气管肺泡灌洗中的IgA抗体水平显著。与接受两种抗原的家兔相比,仅接种一种抗原(PMT或CN)的家兔抗体滴度较低,肝脏和肺部感染为中度至重度,ASC较少。对照组家兔肝脏和肺部感染为中度至重度。本研究表明,用PMT和CN进行鼻内免疫可诱导针对同源多杀性巴氏杆菌攻毒的有效反应。